Medtronic Renews Commitment To Stent Market Via $3.7 Bil. AVE Purchase
This article was originally published in The Gray Sheet
Developing the peripheral stent market will be a top priority for the combined Medtronic/Arterial Vascular Engineering vascular business upon completion of the two companies' $3.7 bil. merger agreement, Medtronic President and Chief Operating Officer Art Collins said during a Nov. 30 teleconference.
You may also be interested in...
Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.